Compound (R) -N*6*-ethyl-6, 7-dihydro-5H-indeno (5, 6d) thiazole2, 6-diamine and the use as antipsychotics

Details for Australian Patent Application No. 2009215920 (hide)

Owner AstraZeneca AB

Inventors Steelman, Gary; Liu, Jianwei; Blackwell III, William C.; Urbanek, Rebecca; Hulsizer, James; Wu, Ye; Widzowski, Dan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009215920

PCT Pub. Number WO2009/105026

Priority 61/030,332 21.02.08 US

Filing date 20 February 2009

Wipo publication date 27 August 2009

International Classifications

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/105026 Priority application(s): WO2009/105026

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215934-Mesenchymal stem cell particles

2009215897-Lacrimal implants and related methods